Tinti F, Lai S, Umbro I, Mordenti M, Barile M, Ginanni Corradini S, Rossi M, Poli L, Nofroni I, Berloco P B, Mitterhofer A P
DAI Nefro-Urologico, Specialità Chirurgiche e Trapianti d'Organo Paride Stefanini, Rome, Italy.
Transplant Proc. 2010 May;42(4):1229-32. doi: 10.1016/j.transproceed.2010.03.129.
Assessment of renal function in patients with end-stage liver disease (ESLD) awaiting liver transplantation (OLT) is critical. Various conditions may cause renal damage in ESLD. Renal and liver functions are intertwined due to splanchnic hemodynamic relationships; renal failure rarely occurs in patients without advanced decompensated cirrhosis. The recent literature suggests that evaluation of renal function should include an assessment of liver function. The aim of this study was to evaluate different methods to estimate glomerular filtration rate (GFR) in patient among ESLD candidates for OLT over 1 year. We also correlated renal and hepatic functions. Fifty-two cirrhotic patients Model for End-Stage Liver Disease [MELD] > 10) were enrolled in the study. All patients were evaluated at baseline and every 4 months (T1-T4) thereafter for 1 year. The GFR was calculated by creatinine clearance, and estimated by Cockroft and Gault, Modified Diet Renal Disease (MDRD) 4 and 6 variable and Chronic Kidney Disease-Epidemiology (CKD-EPI) formulae. Hepatic functions were evaluated by MELD score, albumin, bilirubin, and International Normalized Ratio (INR). We observed not statistically significant increase mean value of MELD score, bilirubin, serum creatinine, and blood urea nitrogen and a reduced serum sodium. There were no significant differences among various methods to evaluate GFR at each time over 1 year. We did not observe any association between renal and hepatic function, except at T4 for MELD and GFR estimated with MDRD 4 (P = .009) and 6 (P = .008) parameters or CKD-EPI (P = .036), and MELD and sodium (P = .001). Our results showed that evaluation of renal function in cirrhosis should include an evaluation of hepatic function. In our case, MDRD and CKD-EPI seemed to be the more accurate formulae to evaluate renal function in relation to hepatic function.
对等待肝移植(OLT)的终末期肝病(ESLD)患者的肾功能评估至关重要。多种情况可能导致ESLD患者出现肾损伤。由于内脏血流动力学关系,肾功能和肝功能相互交织;在没有晚期失代偿性肝硬化的患者中很少发生肾衰竭。最近的文献表明,肾功能评估应包括肝功能评估。本研究的目的是评估在1年时间里对OLT候选ESLD患者估计肾小球滤过率(GFR)的不同方法。我们还对肾功能和肝功能进行了相关性分析。52例肝硬化患者(终末期肝病模型[MELD]>10)纳入本研究。所有患者在基线时以及此后每4个月(T1 - T4)进行为期1年的评估。通过肌酐清除率计算GFR,并采用Cockroft和Gault公式、改良肾病饮食(MDRD)4变量和6变量公式以及慢性肾脏病流行病学(CKD - EPI)公式进行估算。通过MELD评分、白蛋白、胆红素和国际标准化比值(INR)评估肝功能。我们观察到MELD评分、胆红素、血清肌酐和血尿素氮的平均值有非统计学意义的升高,血清钠降低。在1年中的每次评估时,评估GFR的各种方法之间没有显著差异。我们未观察到肾功能和肝功能之间存在任何关联,除了在T4时,MELD与用MDRD 4(P = 0.009)和6(P = 0.008)参数或CKD - EPI(P = 0.036)估算的GFR之间,以及MELD与钠(P = 0.001)之间。我们的结果表明,肝硬化患者的肾功能评估应包括肝功能评估。在我们的病例中,MDRD和CKD - EPI似乎是与肝功能相关的评估肾功能更准确的公式。